Groups | Days after | Haematological parameters | Immunological parameters | ||||
---|---|---|---|---|---|---|---|
MCH (pg) | MCHC (g/dl) | Haematocrit (%) | Lysozyme activity (units/ml) | Phagocytic activity (%) | Antibody level (IgM) (450 nm) | ||
Unvaccinated | 7 (dpv) | 14.24 ± 2.24a | 29.43 ± 2.94a | 17.32 ± 4.21a | 93.73 ± 2.08d | 23.41 ± 2.03c | 0.23 ± 0.02a |
BS | 13.75 ± 5.32a | 31.38 ± 3.82a | 17.94 ± 5.26a | 158.35 ± 9.62c | 27.74 ± 1.52b | 0.27 ± 0.06a | |
BF | 13.90 ± 4.22a | 28.96 ± 5.89a | 19.71 ± 4.97a | 212.77 ± 8.98a | 32.00 ± 1.40a | 0.27 ± 0.04a | |
MS | 14.12 ± 3.96a | 30.63 ± 6.67a | 18.52 ± 2.74a | 202.17 ± 4.08a,b | 32.10 ± 1.51a | 0.28 ± 0.03a | |
MA | 13.24 ± 4.87a | 29.91 ± 6.65a | 18.72 ± 5.25a | 192.96 ± 5.50b | 30.84 ± 1.35a | 0.26 ± 0.05a | |
Unvaccinated | 21 (dpv) | 16.71 ± 2.07a | 38.58 ± 3.15a | 17.79 ± 2.24a | 93.60 ± 2.80d | 24.21 ± 3.54b | 0.25 ± 0.03c |
BS | 15.95 ± 1.52a | 39.28 ± 1.74a | 18.58 ± 4.01a | 204.16 ± 9.10a,b | 34.55 ± 2.53a | 0.40 ± 0.08b | |
BF | 14.98 ± 3.23a | 40.91 ± 3.28a | 20.17 ± 5.85a | 264.78 ± 6.99a | 38.27 ± 4.12a | 0.62 ± 0.02a | |
MS | 16.63 ± 2.48a | 43.99 ± 4.86a | 19.44 ± 3.80a | 253.68 ± 6.78a,b | 39.67 ± 6.51a | 0.49 ± 0.09b | |
MA | 13.68 ± 1.45a | 40.92 ± 3.80a | 17.85 ± 6.67a | 242.55 ± 6.26c | 36.28 ± 4.32a | 0.50 ± 0.03b | |
Unvaccinated | 49 (dpv) | 17.10 ± 3.01a | 36.27 ± 2.17a | 16.49 ± 4.41a | 94.75 ± 4.43d | 23.66 ± 3.92b | 0.21 ± 0.04c |
BS | 16.97 ± 4.10a | 38.39 ± 2.47a | 18.86 ± 2.75a | 207.84 ± 9.43c | 33.17 ± 5.10a,b | 0.58 ± 0.03b | |
BF | 15.93 ± 4.16a | 40.75 ± 4.29a | 19.69 ± 4.39a | 325.90 ± 6.02a | 40.88 ± 5.02a | 0.78 ± 0.02a | |
MS | 17.01 ± 4.43a | 40.13 ± 6.58a | 17.86 ± 2.04a | 313.34 ± 5.19a,b | 39.63 ± 7.81a | 0.71 ± 0.01a | |
MA | 15.92 ± 4.05a | 43.45 ± 5.83a | 17.92 ± 3.27a | 303.05 ± 8.57b | 38.92 ± 7.22a | 0.63 ± 0.03a,b |